Title: Induction of CYP26A1 by metabolites of retinoic acid: evidence that CYP26A1 is an important enzyme in the elimination of active retinoids.
Journal: Molecular pharmacology 20150301
Title: Homology models of human all-trans retinoic acid metabolizing enzymes CYP26B1 and CYP26B1 spliced variant.
Journal: Journal of chemical information and modeling 20121022
Title: Cloning and functional studies of a splice variant of CYP26B1 expressed in vascular cells.
Journal: PloS one 20120101
Title: Synthesis and biological evaluation of 3-(1H-imidazol- and triazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propyl derivatives as small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26).
Journal: Journal of medicinal chemistry 20111013
Title: Complete meiosis from human induced pluripotent stem cells.
Journal: Stem cells (Dayton, Ohio) 20110801
Title: Small molecule inhibitors of retinoic acid 4-hydroxylase (CYP26): synthesis and biological evaluation of imidazole methyl 3-(4-(aryl-2-ylamino)phenyl)propanoates.
Journal: Journal of medicinal chemistry 20110428
Title: CYP26B1 plays a major role in the regulation of all-trans-retinoic acid metabolism and signaling in human aortic smooth muscle cells.
Journal: Journal of vascular research 20110101
Title: Local skin pharmacokinetics of talarozole, a new retinoic acid metabolism-blocking agent.
Journal: Skin pharmacology and physiology 20110101
Title: CYP26A1-specific antagonist influence on embryonic implantation, gene expression and endogenous retinoid concentration in rats.
Journal: Reproductive toxicology (Elmsford, N.Y.) 20101101
Title: Both all-trans retinoic acid and cytochrome P450 (CYP26) inhibitors affect the expression of vitamin A metabolizing enzymes and retinoid biomarkers in organotypic epidermis.
Journal: Archives of dermatological research 20090801
Title: The CYP26 inhibitor R115866 potentiates the effects of all-trans retinoic acid on cultured human epidermal keratinocytes.
Journal: The British journal of dermatology 20090301
Title: The involvement of cytochrome p450 (CYP) 26 in the retinoic acid metabolism of human epidermal keratinocytes.
Journal: Biochimica et biophysica acta 20090301
Title: Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis.
Journal: The British journal of dermatology 20090101
Title: Talarozole, a selective inhibitor of P450-mediated all-trans retinoic acid for the treatment of psoriasis and acne.
Journal: Current opinion in investigational drugs (London, England : 2000) 20081101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20080601
Title: Oral R115866 in the treatment of moderate to severe plaque-type psoriasis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV 20070901
Title: Oral R115866 in the treatment of moderate to severe facial acne vulgaris: an exploratory study.
Journal: The British journal of dermatology 20070701
Title: CYP26 inhibitor R115866 increases retinoid signaling in intimal smooth muscle cells.
Journal: Arteriosclerosis, thrombosis, and vascular biology 20070701
Title: Oral retinoic acid metabolism blocking agent Rambazole for plaque psoriasis: an immunohistochemical study.
Journal: The British journal of dermatology 20070201
Title: Cyp26 enzymes generate the retinoic acid response pattern necessary for hindbrain development.
Journal: Development (Cambridge, England) 20070101
Title: Cyp26 genes a1, b1 and c1 are down-regulated in Tbx1 null mice and inhibition of Cyp26 enzyme function produces a phenocopy of DiGeorge Syndrome in the chick.
Journal: Human molecular genetics 20061201
Title: Homology model of human retinoic acid metabolising enzyme cytochrome P450 26A1 (CYP26A1): active site architecture and ligand binding.
Journal: Journal of enzyme inhibition and medicinal chemistry 20060801
Title: Retinoic acid regulates sex-specific timing of meiotic initiation in mice.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20060221
Title: Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor.
Journal: European journal of pharmacology 20050601
Title: Patterning of motor neurons by retinoic acid in the chick embryo hindbrain in vitro.
Journal: Molecular and cellular neurosciences 20030501
Title: R115866 inhibits all-trans-retinoic acid metabolism and exerts retinoidal effects in rodents.
Journal: The Journal of pharmacology and experimental therapeutics 20000401
Title: Diaz P, et al. Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, theHuman Liver Retinoic Acid Hydroxylase. J Med Chem. 2016 Mar 24;59(6):2579-95.
Title: Topletz AR, et al. Induction of CYP26A1 by metabolites of retinoic acid: evidence that CYP26A1 is an important enzyme in theelimination of active retinoids. Mol Pharmacol. 2015;87(3):430-41.
Title: Faith Stevison, et al. CYP26 Inhibition Increases Retinoic Acid Concentrations in Target Tissues and Alters Retinoid Signaling
Title: Tripathy S, et al.All-Trans-Retinoic Acid Enhances Mitochondrial Function in Models of Human Liver. Mol Pharmacol. 2016 May;89(5):560-74.
Title: Bovenschen HJ, et al. Oral retinoic acid metabolism blocking agent Rambazole for plaque psoriasis: an immunohistochemical study. Br J Dermatol. 2007 Feb;156(2):263-70.
